Progression of Alzheimer's disease as measured by Clinical Dementia Rating Sum of Boxes scores-Reference-Cited by-同舟云学术

Progression of Alzheimer's disease as measured by Clinical Dementia Rating Sum of Boxes scores

Published:2012-08-03 Issue:1S Volume:9 Page:
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Williams Monique M.¹²³,Storandt Martha¹⁴,Roe Catherine M.¹⁵,Morris John C.¹⁵⁶⁷⁸

Affiliation:

1. Charles F. and Joanne Knight Alzheimer's Disease Research CenterWashington UniversitySt. LouisMOUSA

2. Department of MedicineWashington UniversitySt. LouisMOUSA

3. Department of PsychiatryWashington UniversitySt. LouisMOUSA

4. Department of PsychologyWashington UniversitySt. LouisMOUSA

5. Department of NeurologyWashington UniversitySt. LouisMOUSA

6. Department of Pathology and ImmunologyWashington UniversitySt. LouisMOUSA

7. Program in Physical TherapyWashington UniversitySt. LouisMOUSA

8. Program in Occupational TherapyWashington UniversitySt. LouisMOUSA

Funder

National Institute on Aging

National Center for Research Resources

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2012.01.005

Reference41 articles.

1. The evaluation of disease modifying therapies in Alzheimer's disease: a regulatory viewpoint

2. A New Clinical Scale for the Staging of Dementia

3. The Clinical Dementia Rating (CDR)

4. Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type;Morris J.C.;Int Psychogeriatr,1997

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects silymarin and rosuvastatin on amyloid-carriers level in dyslipidemic Alzheimer’s patients: A double-blind placebo-controlled randomized clinical trial;IBRO Neuroscience Reports;2024-12

2. Characterizing the clinical heterogeneity of early symptomatic Alzheimer’s disease: a data-driven machine learning approach;Frontiers in Aging Neuroscience;2024-08-12

3. Technology Usability for People Living With Dementia: Concept Analysis;JMIR Aging;2024-07-03

4. Assessing Quality of Life, Economic Burden, and Independence Across the Alzheimer’s Disease Continuum Using Patient-Caregiver Dyad Surveys;Journal of Alzheimer's Disease;2024-04-30

5. Alzheimer’s Disease Detection Using Deep Learning on Neuroimaging: A Systematic Review;Machine Learning and Knowledge Extraction;2024-02-21